1. Home
  2. RLAY vs UPBD Comparison

RLAY vs UPBD Comparison

Compare RLAY & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.69

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$18.77

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
UPBD
Founded
2015
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
RLAY
UPBD
Price
$7.69
$18.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$16.00
$32.50
AVG Volume (30 Days)
2.1M
742.9K
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
8.27%
EPS Growth
N/A
N/A
EPS
N/A
1.45
Revenue
$8,355,000.00
$4,577,844,000.00
Revenue This Year
$20.47
$10.45
Revenue Next Year
N/A
$8.03
P/E Ratio
N/A
$12.99
Revenue Growth
N/A
7.48
52 Week Low
$1.78
$15.82
52 Week High
$8.36
$34.86

Technical Indicators

Market Signals
Indicator
RLAY
UPBD
Relative Strength Index (RSI) 58.73 50.76
Support Level $7.23 $17.49
Resistance Level $8.36 $19.49
Average True Range (ATR) 0.51 0.72
MACD 0.05 0.38
Stochastic Oscillator 69.18 80.93

Price Performance

Historical Comparison
RLAY
UPBD

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: